1. Synthetic and plant origin active substances design and development with biocompatible polymers.
  2. Nano- and micro-sized drug design and development. 
  3. Formulations design and development for water poorly soluble or water-insoluble drugs. 
  4. Liposome, Niosome, (Solid Lipid Nanoparticle) SLN, such lipid-based formulations design, and development. 
  5. Design and development of Orodispersible/Oral dissolving tablets (ODT), Orodispersible/Oral dissolving thin films (OTF), and controlled release (extended or delayed) polymeric drug formulations.
  6. Evaluation of prepared new drug formulations with preclinical and clinical studies.